Borthwick Kathleen bought PASG
December 31, 2023 · Form 4 insider transaction
Borthwick Kathleen bought 30,000 shares of Passage Bio, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
N/A
Total value
N/A
InsiderBorthwick Kathleen
RoleOfficer
CompanyPassage Bio, Inc. (PASG)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 31, 2023
Filing dateJanuary 3, 2024
Shares owned after36,608
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.; Includes 3,082 shares acquired on May 13, 2022 and 3,526 shares acquired on November 15, 2023 under the 2020 Employee Stock Purchase Plan.